CARIM 2013-2018_Case studies_0.pdf
(3.19 MB, PDF)
… industry (contracts with Bayer, Daichio Sankyo, Boehringer Ingelheim). After we demonstrated that VKA treatment resulted in increased and accelerated vascular and valvular calcification, our research group got back in contact with the Norwegian stock- exchanged company NattoPharma ASA. With VitaK the research with NattoPharma resulted in a five-year research budget exceeding 3 M€. My research within CARIM led to a renewed collaboration with currently two PhD positions sponsored by NattoPharma. … research meetings in which CARIM researchers from the Dept. of Cardiology, Dept. Physiology and Dept. of Biomedical Engineering, as well as collaborators from the Faculty of Science and Engineering, participate. These meetings provide a platform to exchange ideas, share expertise and identify new opportunities for joint projects. In addition, the topic of modelling cardiac electrophysiology is regularly part of the Maastricht Systems Biology Forum meetings, a quarterly event bringing together all … students with medical background as well as biomedical engineers, medical technician and biomedical scientists. Many of these students continue in the field by specialisation in disciplines like cardiology or cardiac surgery. There is a regular exchange of investigators between our group and the abovementioned institutes, frequently resulting in internships or secondments at each other’s labs as well as visiting professorships. Scientific quality The scientific quality of the research is …